- Home
- IMNM vs ZIONP Comparison
IMNM vs ZIONP Comparison
Compare IMNM & ZIONP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- ZIONP
- Stock Information
- Founded
- IMNM 2006
- ZIONP N/A
- Country
- IMNM United States
- ZIONP United States
- Employees
- IMNM N/A
- ZIONP 9679
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- ZIONP Major Banks
- Sector
- IMNM Health Care
- ZIONP Finance
- Exchange
- IMNM Nasdaq
- ZIONP Nasdaq
- Market Cap
- IMNM 747.7M
- ZIONP N/A
- IPO Year
- IMNM 2020
- ZIONP N/A
- Fundamental
- Price
- IMNM $10.97
- ZIONP $23.59
- Analyst Decision
- IMNM Strong Buy
- ZIONP
- Analyst Count
- IMNM 5
- ZIONP 0
- Target Price
- IMNM $28.60
- ZIONP N/A
- AVG Volume (30 Days)
- IMNM 911.8K
- ZIONP N/A
- Earning Date
- IMNM 11-13-2024
- ZIONP N/A
- Dividend Yield
- IMNM N/A
- ZIONP N/A
- EPS Growth
- IMNM N/A
- ZIONP N/A
- EPS
- IMNM N/A
- ZIONP N/A
- Revenue
- IMNM $10,129,000.00
- ZIONP N/A
- Revenue This Year
- IMNM N/A
- ZIONP N/A
- Revenue Next Year
- IMNM N/A
- ZIONP N/A
- P/E Ratio
- IMNM N/A
- ZIONP N/A
- Revenue Growth
- IMNM N/A
- ZIONP N/A
- 52 Week Low
- IMNM $8.33
- ZIONP N/A
- 52 Week High
- IMNM $30.96
- ZIONP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 39.61
- ZIONP 55.35
- Support Level
- IMNM $10.76
- ZIONP $23.23
- Resistance Level
- IMNM $15.13
- ZIONP $24.15
- Average True Range (ATR)
- IMNM 0.98
- ZIONP 0.31
- MACD
- IMNM -0.29
- ZIONP -0.00
- Stochastic Oscillator
- IMNM 4.81
- ZIONP 38.62
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.
About ZIONP Zions Bancorporation N.A.
Zions Bancorporation is a regional us bank with core operations that span 11 states. The bank is headquartered in Salt Lake City and does business primarily in the Western and Southwestern United States. Zions primarily focuses on providing banking services to small and midsize businesses, with the bulk of its loans focused on commercial and commercial real estate lending.